Both in Pharmaceuticals
Crescent Biopharma vs Capricor Therapeutics
Over the past year CBIO returned −5.6% and CAPR returned +7.4%; their daily moves had a correlation of 0.12.
CBIO −5.6% CAPR +7.4%Growth of $1, one year, split-adjusted
| Metric | CBIO | CAPR |
|---|---|---|
| Price | $11.84 | $6.71 |
| Market cap | $439.8M | $390.1M |
| Today | −5.13% | −7.70% |
| 1 month | −29.4% | −28.8% |
| 6 months | −44.4% | −80.7% |
| Year to date | −0.2% | −76.7% |
| 1 year | +4.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 37.0× | — |
| Net cash | $171.6M | $237.9M |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | 269.5% |
| Short % of float | 22.9% | 45.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).